Dr. Cynthia Boyd is the Mason F. Lord Professor of Medicine at the Johns Hopkins University School of Medicine. Dr. Boyd is the Director, Division of Geriatric Medicine and Gerontology. She holds a joint appointment in Health Policy and Management and Epidemiology at the Johns Hopkins Bloomberg School of Public Health. Dr. Boyd is a faculty member at the Center for Transformative Geriatric Research, Johns Hopkins Center on Aging and Health and the Roger and Flo Lipitz Center to Advance Policy in Aging and Disability. A former Robert Wood Johnson Physician Faculty Scholar and a Beeson Scholar, Dr. Boyd is trained in internal medicine, geriatric medicine and epidemiology. Dr. Boyd’s career has focused on improving the health and well-being of older adults with multiple chronic conditions, with robust research and mentoring programs that have helped launch the careers of multiple junior faculty, fellows, medical students and other learners. Dr. Boyd is MPI of the NIA-funded US Deprescribing Research Network, has studied the inappropriate use of medications where harm may outweigh benefits, and has extensive experience leading and evaluating interventions to improve health for older adults. She earned her M.D. from the Duke University School of Medicine and her M.P.H. from the University of North Carolina at Chapel Hill. She completed her residency at Johns Hopkins Hospital and performed a fellowship in geriatric medicine at Johns Hopkins Bayview Medical Center. Dr. Boyd currently practices primary care and consultative geriatric care for older adults in Baltimore. Dr. Boyd has been recognized with several honors, including the American Geriatric Society’s Outstanding Scientific Achievement for Clinical Investigation Award, election to the American Society for Clinical Investigation, and Fellowship in the American College of Physicians and the American Geriatric Society. Her research has been funded by the NIH, AHRQ, PCORI, and foundations.

Dr. Goyal is a heart failure cardiologist and health services researcher with formal training in epidemiology and implementation science. He has a faculty appointment as an Associate Professor of Medicine at Weill Cornell Medicine. He is particularly interested in improving outcomes and the wellbeing of older adults with heart failure. Towards this end, he is the Founding Director of the Heart Failure with Preserved Ejection Fraction (HFpEF) Program and Director of the Cardiac Amyloidosis Program at Weill Cornell Medicine. These programs anchor Dr. Goyal’s Program for the Care and Study of the Aging Heart, which is a geriatric cardiology program that seeks to advance the science of cardiovascular aging and age-related cardiovascular conditions by developing, studying, and implementing innovative patient-centered approaches to cardiovascular care. Over the years, Dr. Goyal has published >250 peer-reviewed manuscripts, leading studies published in high-impact journals including the New England Journal of Medicine. Dr. Goyal studies polypharmacy in heart failure, and has been working to advance deprescribing efforts within the cardiovascular field. This includes leveraging N-of-1 trials to promote shared decision making and deprescribing. His work has been supported by extensive extramural funding which includes multiple grants from the National Institute on Aging (R03, K76, R21, R01x3), the American Heart Association (Innovative Project Award and Career Development Award), and multiple foundations.

Richard Lindley is Professor of Geriatric Medicine, University of Sydney, and currently the Director of the NHMRC Centre of Research Excellence for Stroke Trial Innovation and Translation.

Associate Professor Ingrid Hopper is a consultant physician at the Alfred Hospital and Associate Professor in the School of Public Health and Preventive Medicine at Monash University, Melbourne, Australia. She has specialist training in internal medicine, clinical pharmacology, epidemiology and public health. Her research spans cardiovascular therapeutics, primary prevention and healthy ageing, with a focus on the pharmacological prevention and management of cardiac ageing—including heart failure and atrial fibrillation—and on optimising medication use and models of care for older adults. She has extensive experience in clinical trials, pharmacoepidemiology and implementation research, and her work aims to improve the prevention and management of cardiovascular disease through evidence-based pharmacotherapy. She has published widely in cardiovascular medicine and healthy ageing and contributes to national and international collaborative research in cardiovascular prevention.